Markus Kalla

671 total citations
9 papers, 517 citations indexed

About

Markus Kalla is a scholar working on Oncology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Markus Kalla has authored 9 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Epidemiology and 2 papers in Infectious Diseases. Recurrent topics in Markus Kalla's work include Viral-associated cancers and disorders (5 papers), Cytomegalovirus and herpesvirus research (4 papers) and Parvovirus B19 Infection Studies (2 papers). Markus Kalla is often cited by papers focused on Viral-associated cancers and disorders (5 papers), Cytomegalovirus and herpesvirus research (4 papers) and Parvovirus B19 Infection Studies (2 papers). Markus Kalla collaborates with scholars based in Germany, United States and Switzerland. Markus Kalla's co-authors include Wolfgang Hammerschmidt, William Zhang, Cristina Balagué, Christine Göbel, Dagmar Pich, Anna Benet‐Pagès, Sebastian Eck, Ulrich Rothbauer, Tim M. Strom and Henri‐Jacques Delecluse and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Virology and Scientific Reports.

In The Last Decade

Markus Kalla

9 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Markus Kalla Germany	7	337	213	155	122	105	9	517
Mark Bain United Kingdom	11	276 0.8×	311 1.5×	128 0.8×	48 0.4×	110 1.0×	11	537
Stacy R. Hagemeier United States	11	395 1.2×	227 1.1×	171 1.1×	28 0.2×	120 1.1×	13	549
Horng-Shen Chen United States	11	470 1.4×	356 1.7×	151 1.0×	34 0.3×	113 1.1×	12	647
Janet Hearing United States	12	295 0.9×	189 0.9×	117 0.8×	47 0.4×	40 0.4×	15	464
Erik Gustafson United States	7	170 0.5×	210 1.0×	87 0.6×	42 0.3×	63 0.6×	10	377
Kostas Paschos United Kingdom	11	453 1.3×	155 0.7×	177 1.1×	28 0.2×	189 1.8×	13	581
Lee-Wen Chen Taiwan	12	289 0.9×	263 1.2×	62 0.4×	25 0.2×	49 0.5×	25	412
Anne Müller Switzerland	10	158 0.5×	218 1.0×	76 0.5×	32 0.3×	190 1.8×	24	449
Andrea Knappe Germany	9	337 1.0×	257 1.2×	60 0.4×	78 0.6×	378 3.6×	9	674
Julianna Stylianou United Kingdom	7	202 0.6×	172 0.8×	64 0.4×	33 0.3×	98 0.9×	9	336

Countries citing papers authored by Markus Kalla

Since Specialization

Citations

This map shows the geographic impact of Markus Kalla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Kalla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Kalla more than expected).

Fields of papers citing papers by Markus Kalla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Kalla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Kalla. The network helps show where Markus Kalla may publish in the future.

Co-authorship network of co-authors of Markus Kalla

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Kalla. A scholar is included among the top collaborators of Markus Kalla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Kalla. Markus Kalla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Hinterberger, Maria, Kathrin Endt, Barbara Bathke, et al.. (2023). Preclinical development of a first-in-class vaccine encoding HER2, Brachyury and CD40L for antibody enhanced tumor eradication. Scientific Reports. 13(1). 5162–5162. 1 indexed citations

Endt, Kathrin, Markus Kalla, Hubertus Hochrein, et al.. (2022). A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection. Frontiers in Immunology. 13. 841471–841471. 15 indexed citations

Steigerwald, Robin, David A. Brake, José Barrera, et al.. (2019). Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle. Vaccine. 38(4). 769–778. 3 indexed citations

Kalla, Markus & Wolfgang Hammerschmidt. (2011). Human B cells on their route to latent infection – Early but transient expression of lytic genes of Epstein-Barr virus. European Journal of Cell Biology. 91(1). 65–69. 63 indexed citations

Kalla, Markus, Christine Göbel, & Wolfgang Hammerschmidt. (2011). The Lytic Phase of Epstein-Barr Virus Requires a Viral Genome with 5-Methylcytosine Residues in CpG Sites. Journal of Virology. 86(1). 447–458. 55 indexed citations

Kalla, Markus, Christine Göbel, Ulrich Rothbauer, et al.. (2010). CpG-Methylation Regulates a Class of Epstein-Barr Virus Promoters. PLoS Pathogens. 6(9). e1001114–e1001114. 91 indexed citations

Kalla, Markus, et al.. (2010). Toll-Like Receptor Agonists Synergistically Increase Proliferation and Activation of B Cells by Epstein-Barr Virus. Journal of Virology. 84(7). 3612–3623. 43 indexed citations

Kalla, Markus, et al.. (2009). AP-1 homolog BZLF1 of Epstein–Barr virus has two essential functions dependent on the epigenetic state of the viral genome. Proceedings of the National Academy of Sciences. 107(2). 850–855. 130 indexed citations

Balagué, Cristina, Markus Kalla, & William Zhang. (1997). Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome. Journal of Virology. 71(4). 3299–3306. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact